GRAZIANI, GRAZIA
 Distribuzione geografica
Continente #
NA - Nord America 4.661
EU - Europa 1.896
AS - Asia 1.483
AF - Africa 85
SA - Sud America 50
OC - Oceania 45
Continente sconosciuto - Info sul continente non disponibili 5
Totale 8.225
Nazione #
US - Stati Uniti d'America 4.507
IT - Italia 594
CN - Cina 498
DE - Germania 336
IN - India 302
GB - Regno Unito 174
FR - Francia 171
CA - Canada 110
JP - Giappone 88
SE - Svezia 80
KR - Corea 78
IR - Iran 69
RU - Federazione Russa 69
VN - Vietnam 64
ES - Italia 53
CZ - Repubblica Ceca 51
HK - Hong Kong 51
TW - Taiwan 51
IE - Irlanda 49
NL - Olanda 46
PL - Polonia 46
TR - Turchia 44
TH - Thailandia 41
MX - Messico 39
AU - Australia 38
UA - Ucraina 33
ZA - Sudafrica 33
AE - Emirati Arabi Uniti 30
RO - Romania 28
FI - Finlandia 27
EG - Egitto 26
BR - Brasile 24
ID - Indonesia 24
IQ - Iraq 23
SI - Slovenia 23
MY - Malesia 19
SG - Singapore 19
PH - Filippine 18
CH - Svizzera 17
BE - Belgio 14
PK - Pakistan 14
PT - Portogallo 13
GR - Grecia 12
SA - Arabia Saudita 12
CL - Cile 11
BD - Bangladesh 10
RS - Serbia 10
AR - Argentina 7
AT - Austria 7
DK - Danimarca 7
MK - Macedonia 7
NZ - Nuova Zelanda 7
TN - Tunisia 7
IL - Israele 5
PE - Perù 5
SK - Slovacchia (Repubblica Slovacca) 5
DZ - Algeria 4
EU - Europa 4
HU - Ungheria 4
LT - Lituania 4
NG - Nigeria 4
BG - Bulgaria 3
BT - Bhutan 3
JO - Giordania 3
KH - Cambogia 3
MO - Macao, regione amministrativa speciale della Cina 3
NO - Norvegia 3
QA - Qatar 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
EC - Ecuador 2
EE - Estonia 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
KE - Kenya 2
LB - Libano 2
UZ - Uzbekistan 2
AP - ???statistics.table.value.countryCode.AP??? 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
GH - Ghana 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LY - Libia 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SO - Somalia 1
TT - Trinidad e Tobago 1
Totale 8.225
Città #
Woodbridge 751
Houston 518
Fairfield 349
Santa Cruz 278
Ashburn 237
Buffalo 233
Wilmington 195
Seattle 192
Rome 162
Ann Arbor 129
Cambridge 117
Beijing 97
Milan 68
University Park 58
Stockholm 57
Shanghai 56
Chicago 54
Mountain View 50
Dublin 43
Bengaluru 41
San Diego 36
Guangzhou 35
Simi Valley 35
Clearwater 34
Hangzhou 34
Nanjing 33
Taipei 32
Las Vegas 29
Ottawa 29
New York 27
Wuhan 26
Boardman 25
Hyderabad 25
Hanoi 24
Madrid 24
Mumbai 24
Nürnberg 24
San Francisco 24
Chennai 23
Los Angeles 23
Muizenberg 23
Phoenix 23
Helsinki 21
Dong Ket 20
Tokyo 20
Mexico City 19
Delhi 18
Henderson 17
London 17
Columbus 16
Jinan 16
Napoli 16
Riva 16
Central District 15
Istanbul 15
Kraków 14
Dallas 13
Frankfurt am Main 13
Paris 13
Pune 13
Scarborough 13
Central 12
Council Bluffs 12
Easton 12
Ho Chi Minh City 12
Yellowknife 12
Ahmedabad 11
Chengdu 10
Jakarta 10
Saint Petersburg 10
Singapore 10
Toronto 10
Barcelona 9
Bologna 9
Jeddah 9
Kirovsk 9
Lake Forest 9
Leawood 9
Naples 9
Raleigh 9
San Jose 9
Seoul 9
Sydney 9
Tabriz 9
Turin 9
Amsterdam 8
Austin 8
Chiang Mai 8
Chiba 8
Florence 8
Kuala Lumpur 8
Marcellina 8
Tehran 8
Ankara 7
Atlanta 7
Baghdad 7
Büdelsdorf 7
Cairo 7
Changsha 7
Chaoyang 7
Totale 4.953
Nome #
Strategies to improve ellagic acid bioavailability: from natural or semisynthetic derivatives to nanotechnological approaches based on innovative carriers, file e291c0d8-f563-cddb-e053-3a05fe0aa144 1.480
Monoclonal antibodies to CTLA-4 with focus on ipilimumab, file e291c0d4-c1bc-cddb-e053-3a05fe0aa144 665
BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib., file e291c0d4-c485-cddb-e053-3a05fe0aa144 476
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1, file e291c0d4-aaae-cddb-e053-3a05fe0aa144 378
Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression, file e291c0d4-b971-cddb-e053-3a05fe0aa144 373
Ellagic acid inhibits bladder cancer invasiveness and in vivo tumor growth, file e291c0d6-3e98-cddb-e053-3a05fe0aa144 340
The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges, file e291c0d8-ae48-cddb-e053-3a05fe0aa144 322
Cilengitide down-modulates invasiveness and vasculogenic mimicry of neuropilin-1 expressing melanoma cells through the inhibition of αvβ5 integrin., file e291c0d4-a3f6-cddb-e053-3a05fe0aa144 282
Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness., file e291c0d4-89e2-cddb-e053-3a05fe0aa144 242
null, file e291c0d7-d353-cddb-e053-3a05fe0aa144 219
High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro, file e291c0d6-a978-cddb-e053-3a05fe0aa144 217
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding, file e291c0d6-3dd7-cddb-e053-3a05fe0aa144 209
Neuropilin-1 as Therapeutic Target for Malignant Melanoma., file e291c0d5-d44f-cddb-e053-3a05fe0aa144 198
PARP Inhibitors in Cancer Therapy: Magic Bullets but Moving Targets., file e291c0d4-89e4-cddb-e053-3a05fe0aa144 181
Reduced proficiency in homologous recombination underlies the high sensitivity of embryonal carcinoma testicular germ cell tumors to Cisplatin and poly (adp-ribose) polymerase inhibition, file e291c0d4-b8f3-cddb-e053-3a05fe0aa144 179
Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers., file e291c0d4-9d8c-cddb-e053-3a05fe0aa144 168
The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells, file e291c0d6-d24c-cddb-e053-3a05fe0aa144 168
NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug., file e291c0d4-c072-cddb-e053-3a05fe0aa144 166
PARP-1 modulates amyloid beta peptide-induced neuronal damage., file e291c0d4-b7c1-cddb-e053-3a05fe0aa144 162
null, file e291c0d4-b78a-cddb-e053-3a05fe0aa144 161
null, file e291c0d6-db10-cddb-e053-3a05fe0aa144 159
Role of VEGFs/VEGFR-1 signaling and its inhibition in modulating tumor invasion: experimental evidence in different metastatic cancer models, file e291c0d8-2ff7-cddb-e053-3a05fe0aa144 143
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome, file e291c0d6-3711-cddb-e053-3a05fe0aa144 132
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints, file c42aad10-16f2-4f82-9a6c-2dd35710d09a 120
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB, file e291c0d4-b7be-cddb-e053-3a05fe0aa144 116
Targeting tumor-associated macrophages to increase the efficacy of immune checkpoint inhibitors: a glimpse into novel therapeutic approaches for metastatic melanoma, file e291c0d8-9f71-cddb-e053-3a05fe0aa144 112
Role of VEGFR-1 in melanoma acquired resistance to the BRAF inhibitor vemurafenib, file e291c0d7-de4f-cddb-e053-3a05fe0aa144 107
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes, file e291c0d7-b022-cddb-e053-3a05fe0aa144 105
Experimental evidence of the antitumor, antimetastatic and antiangiogenic activity of ellagic acid, file e291c0d7-e71b-cddb-e053-3a05fe0aa144 93
EGFR heterogeneity and implications for therapeutic intervention in glioblastoma., file e291c0d7-e720-cddb-e053-3a05fe0aa144 85
Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2, file e291c0d8-fb30-cddb-e053-3a05fe0aa144 84
Role of BRCA mutations in cancer treatment with poly(ADP-ribose) polymerase (PARP) inhibitors, file e291c0d8-0757-cddb-e053-3a05fe0aa144 80
Saffron and its major ingredients’ effect on colon cancer cells with mismatch repair deficiency and microsatellite instability, file e291c0d9-8e1b-cddb-e053-3a05fe0aa144 60
PDIA3 Expression in Glioblastoma Modulates Macrophage/Microglia Pro-Tumor Activation, file e291c0d8-fa12-cddb-e053-3a05fe0aa144 58
At the cutting edge against cancer: A perspective on immunoproteasome and immune checkpoints modulation as a potential therapeutic intervention, file e291c0d9-98da-cddb-e053-3a05fe0aa144 57
The poly(ADP-ribose) polymerase inhibitor olaparib induces up-regulation of death receptors in primary acute myeloid leukemia blasts by NF-κB activation., file e291c0d9-ef2f-cddb-e053-3a05fe0aa144 56
High-Dose Vitamin C: Preclinical Evidence for Tailoring Treatment in Cancer Patients, file e291c0d9-286d-cddb-e053-3a05fe0aa144 51
hTERT Transduction Extends the Lifespan of Primary Pediatric Low-Grade Glioma Cells While Preserving the Biological Response to NGF, file e291c0d9-3834-cddb-e053-3a05fe0aa144 48
VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody, file e291c0d9-d81e-cddb-e053-3a05fe0aa144 37
Editorial, file e291c0d8-bbbc-cddb-e053-3a05fe0aa144 33
Ipilimumab: A novel immunostimulatory monoclonal antibody for the treatment of cancer, file e291c0d4-b7bc-cddb-e053-3a05fe0aa144 29
Placenta growth factor induces melanoma resistance to temozolomide through a mechanism that involves the activation of the transcription factor NF-κB, file e291c0d4-b7bf-cddb-e053-3a05fe0aa144 29
Insulin-degrading enzyme Is a non proteasomal target of carfilzomib and affects the 20S proteasome inhibition by the drug, file e291c0d9-bff8-cddb-e053-3a05fe0aa144 24
Novel frontiers in neuroprotective therapies in glaucoma: Molecular and clinical aspects, file 24b7954c-ef5f-493e-aaee-5f8ca6b7bf90 20
Targeting of PDGF-C/NRP-1 autocrine loop as a new strategy for counteracting the invasiveness of melanoma resistant to braf inhibitors, file 524c0056-1d4a-47d9-81d7-ddec6d82eff5 20
Targeted therapy for brain tumours: role of PARP inhibitors, file e291c0d4-b7c3-cddb-e053-3a05fe0aa144 13
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells, file e291c0d4-b803-cddb-e053-3a05fe0aa144 12
Type 5 phosphodiesterase regulates glioblastoma multiforme aggressiveness and clinical outcome, file e291c0d6-3712-cddb-e053-3a05fe0aa144 12
Modulation of GDF11 expression and synaptic plasticity by age and training, file e291c0d8-6a3b-cddb-e053-3a05fe0aa144 11
PARP1 allows proper telomere replication through TRF1 poly (ADP-ribosyl)ation and helicase recruitment, file 3caea4ab-29ad-43b3-8223-d277c0f3ee28 8
The Anti-Vascular Endothelial Growth Factor Receptor 1 (VEGFR-1) D16F7 Monoclonal Antibody Inhibits Melanoma Adhesion to Soluble VEGFR-1 and Tissue Invasion in Response to Placenta Growth Factor, file defeef27-9957-48d2-ad15-587347f2fb40 8
Challenging resistance mechanisms to therapies for metastatic melanoma, file e291c0d4-88b2-cddb-e053-3a05fe0aa144 8
Mutations of human DNA topoisomerase I at poly(ADP-ribose) binding sites: modulation of camptothecin activity by ADP-ribose polymers., file e291c0d9-85ab-cddb-e053-3a05fe0aa144 7
A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib, file e291c0d4-cc47-cddb-e053-3a05fe0aa144 6
Effects of Glutathione Transferase-Targeting Nitrobenzoxadiazole Compounds in Relation to PD-L1 Status in Human Melanoma Cells, file e291c0d8-0326-cddb-e053-3a05fe0aa144 6
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain?, file e291c0d8-5a7c-cddb-e053-3a05fe0aa144 6
Exogenous Control of the Expression of Group I CD1 Molecules Competent for Presentation of Microbial Nonpeptide Antigens to Human T Lymphocytes, file e291c0d4-b787-cddb-e053-3a05fe0aa144 5
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma, file e291c0d4-b807-cddb-e053-3a05fe0aa144 5
The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design, file 353e83ce-008d-4729-a79c-293c7c8186b5 2
Exploiting Microglial Functions for the Treatment of Glioblastoma, file e291c0d6-2f9d-cddb-e053-3a05fe0aa144 2
Lead Discovery of Dual G-Quadruplex Stabilizers and Poly(ADP-ribose) Polymerases (PARPs) Inhibitors: A New Avenue in Anticancer Treatment, file e291c0d6-b15c-cddb-e053-3a05fe0aa144 2
The Anti-Vascular Endothelial Growth Factor Receptor-1 Monoclonal Antibody D16F7 Inhibits Glioma Growth and Angiogenesis In Vivo., file e291c0d6-d5ff-cddb-e053-3a05fe0aa144 2
Beneficial and Detrimental Effects of Antiretroviral Therapy on HIV-Associated Immunosenescence, file e291c0d7-d16b-cddb-e053-3a05fe0aa144 2
Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review, file 544caa1e-4fc1-4a3f-989a-f288bb5744e7 1
Targeting immunoproteasome in neurodegeneration: a glance to the future, file c6d90465-d5ef-4489-bbd4-ba4d3538857b 1
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies, file e291c0d3-d561-cddb-e053-3a05fe0aa144 1
Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide., file e291c0d4-82c7-cddb-e053-3a05fe0aa144 1
GITRL (Glucocorticoid-Induced TNF receptor family-Related Ligand) triggering up-regulates VCAM-1 and ICAM-1 and promotes leukocyte adhesion., file e291c0d5-324e-cddb-e053-3a05fe0aa144 1
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation, file e291c0d6-3243-cddb-e053-3a05fe0aa144 1
On the Horizon: Targeting Next-Generation Immune Checkpoints for Cancer Treatment, file e291c0d7-e397-cddb-e053-3a05fe0aa144 1
Therapeutic implication of vascular endothelial growth factor receptor-1 (VEGFR-1) targeting in cancer cells and tumor microenvironment by competitive and non-competitive inhibitors, file e291c0d7-e725-cddb-e053-3a05fe0aa144 1
Targeting ADP-ribosylation by PARP inhibitors in acute myeloid leukaemia and related disorders, file e291c0d8-1199-cddb-e053-3a05fe0aa144 1
Vascular endothelial growth factor receptor 1 in glioblastoma-associated microglia/macrophages, file e291c0d8-3148-cddb-e053-3a05fe0aa144 1
DNA inhibitors for the treatment of brain tumors, file e291c0d8-593a-cddb-e053-3a05fe0aa144 1
Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma, file e291c0d8-d721-cddb-e053-3a05fe0aa144 1
Poly(ADP-Ribose) polymerase inhibitors for arsenic trioxide-resistant acute promyelocytic leukemia: synergistic in vitro antitumor effects with hypomethylating agents or high-dose vitamin C, file e291c0d9-189f-cddb-e053-3a05fe0aa144 1
Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research, file e2d4aea6-e078-4f03-878e-cb7a661107f3 1
Totale 8.575
Categoria #
all - tutte 17.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.393


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019328 0 0 0 0 0 0 0 0 0 0 166 162
2019/2020983 112 81 43 89 75 69 78 79 130 73 85 69
2020/20211.115 72 99 53 67 99 121 79 94 84 135 96 116
2021/20221.831 115 133 88 171 163 121 98 175 167 111 355 134
2022/20231.509 92 94 302 201 78 164 82 83 135 72 113 93
2023/20241.107 97 93 101 103 127 98 124 93 108 98 65 0
Totale 8.575